Review: could Cladribine cause Peripheral motor neuropathy?
We study 663 people who have side effects while taking Cladribine from FDA and social media. Among them, 3 have Peripheral motor neuropathy. Find out below who they are, when they have Peripheral motor neuropathy and more.
Stay connected: join a mobile support group for people who take Cladribine and have Peripheral motor neuropathy >>>
Cladribine (latest outcomes from 664 users) has active ingredients of cladribine. It is often used in multiple sclerosis.
Peripheral motor neuropathy
Peripheral motor neuropathy (muscles in the body become progressively weaker over months to years) (latest reports from 3,022 patients) has been reported by people with breast cancer, lung cancer - non-small cell, colon cancer, pain, high blood pressure.
On Aug, 28, 2014: 663 people reported to have side effects when taking Cladribine. Among them, 3 people (0.45%) have Peripheral Motor Neuropathy. They amount to 0.10% of all the 3,016 people who have Peripheral Motor Neuropathy on eHealthMe.
Time on Cladribine when people have Peripheral motor neuropathy * :
Gender of people who have Peripheral motor neuropathy when taking Cladribine * :
|Peripheral motor neuropathy||0.00%||100.00% |
Age of people who have Peripheral motor neuropathy when taking Cladribine * :
|Peripheral motor neuropathy||0.00%||0.00%||0.00%||0.00%||0.00%||100.00%||0.00%||0.00% |
Severity of Peripheral motor neuropathy when taking Cladribine ** :
How people recovered from Peripheral motor neuropathy ** :
Top conditions involved for these people * :
- Chemotherapy (3 people, 100.00%)
- Acute lymphocytic leukaemia (1 people, 33.33%)
Top co-used drugs for these people * :
- Methotrexate (3 people, 100.00%)
- Cytarabine (3 people, 100.00%)
- Dexamethasone (3 people, 100.00%)
- Atriance (3 people, 100.00%)
- Ifosfamide (3 people, 100.00%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
You can also:
Get connected! Join a mobile support group:
- group for people who take Cladribine and have Peripheral Motor Neuropathy
- group for people who take Cladribine
- group for people who have Peripheral Motor Neuropathy
Comments from related studies:
From this study (2 years ago):
I also have tendonitis in both shoulders and tore a bicep muscle. This all started happening 2 days after i stopped meds. Do not take unless it's a matter of life or death. My Peripheral Neuropathy could potentially get worse. To the point of being in a wheelchair. Seriously, do not take this drug unless you are super desperate. Ask if there's an alternative. This stuff is poison for real.
Can you answer these questions (what is this?):
More questions for: Cladribine, Peripheral motor neuropathy
More reviews for: Cladribine, Peripheral motor neuropathy
Drugs in real world that are associated with:
Could your condition cause it?
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.